Results from TAVR Clinical Trial Show Positive Outcomes for Patients in First 30 Days
The researchers from MedStar Heart & Vascular Institute, led by Ron Waksman, MD, found, in their first-of-its-kind trial, that transcatheter aortic valve replacement in patients with low surgical risk showed no deaths or disabling strokes within 30 days of undergoing the procedure. This is a “strong signal” that it is safe for these patients as an alternative to the current standard of care.
Creating a Safer EHR: MedStar Collaborates to Provide Best Practices
A new report by The Pew Charitable Trusts, MedStar Health’s National Center for Human Factors in Healthcare, and the American Medical Association drafts a framework of recommendations for improvements in the usability and safety of electronic health records (EHRs). The report includes suggested best practices for development and implementation of EHRs.
MedStar Researchers to Evaluate Clinical Decision Support Resources
Jointly led by Kristen Miller, DrPH, CPPS, and Zach Hettinger, MD, MS, the MedStar research team has been awarded a federal contract from the Agency for Healthcare Research and Quality to investigate the implementation and efficacy of shareable clinical decision support resources as part of healthcare team communications.
Collaborative Team Publishes Findings from Diabetes Bootcamp Program at MedStar Health
Published online ahead of print in The Journal of Nursing Care Quality, the study sought to identify barriers to implementing a technology-based system to deliver diabetes survival skills education while patients are in the hospital. The educational system helps to send patients home with needed skills to manage their diabetes. The research team is Kelly Smith, PhD; Kelley Baker, MA; Joan Bardsley, MBA, RN, CDE, Patricia McCartney, PhD, RN; and Michelle Magee, MD.